INTRODUCTION
Certain authors have postulated (1 to 4) that the intravenous administration of crystalline trypsin into animals causes a type of shock that is similar to that produced in anaphylaxis or after peptone injection.
The following argument is developed by these authors in order to support this hypothesis. Histamine is released when smooth muscle is perfused with trypsin solution (2) ; and a similar production of histamine occurs in anaphylactic shock (5, 6) . In trypsin shock, a prolonged clotting time of the blood is observed, which these authors attribute to the presence of heparin (7) . In peptone (8) and in anaphylactic shock, delayed coagulation also occurs due to heparin, which has actually been isolated (9) from the blood of dogs in anaphylactic shock.
Since trypsin possesses the power to coagulate blood by converting prothrombin to thrombin even in the absence of ionic calcium (10) , it seemed interesting to determine whether this production of thrombin is a factor in the shockproducing activity of trypsin. Accordingly, the effects of the injection of trypsin and thrombin on the blood pressure and the blood coagulation mechanism were compared in experimental animals.
MATERIAL AND METHOD
Sixty-eight rabbits and 17 mongrel dogs were used as experimental animals. Blood pressure was recorded by a mercury manometer after cannulation of the carotid artery, in rabbits, or the femoral artery, in dogs. Four-tenths ml. per Icgm. of body weight of a 10 per cent solution of nembutal, injected intravenously, was used for anesthesia. The anesthesia was occasionally supplemented with ether during the preparation and cannulation of the artery in rabbits but the administration of ether was discontinued after completion of the operative procedure. Injections were made into the ear vein of the rabbits or into one of the leg veins in dogs. Occasionally, the femoral artery of the dog was used for injection. Unless otherwise specified, all injections were completed within 5 to 15 seconds. Blood samples were taken by syringe and needle from the carotid artery of rabbits or from the jugular vein of dogs. Plasma was obtained from citrated blood by spinning at 2,000 r.p.m. for 15 minutes. One ml. of 2.5 per cent sodium citrate for 9 ml. of blood was used as anticoagulant.
Trypsin. A crystalline trypsin preparation containing 85 per cent magnesium sulfate was dissolved in 10 ml. of physiological saline for injection into rabbits, in 20 ml. of physiological saline for injection into dogs.-Heparin. Lederle heparin solution, containing 10 mgm. per ml., was employed. Each mgm. assays 110 Toronto units.
Thrombin. A pseudo-globulin fraction' prepared from the plasma of rabbits was used as a source of thrombin. The properties of this preparation have been described by several authors (11, 12) . A 12.5 per cent aqueous solution of this readily soluble dry powder was employed.
Fibrinogen. A 0.4 per cent solution in distilled water of a dried preparation, made by alcohol precipitation," was used.
Coagulation time of whole blood. This was measured at 370 C. by the method described by Patek and Stetson (13) .
Coagulation time of recalcified citrated plasma. Citrated plasma was recalcified, using 0.1 ml. of 1.25 per cent CaCl2 for each 0.5 ml. of plasma. The clotting time was measured at 370 C. The clotting time of recalcified plasma has been used in the past as a measure of prothrombin (14) .
Prothrombin. This was estimated at 370 C. by measuring the "prothrombin time," according to Quick. When the quantity of fibrinogen in plasma was found to be abnormally low as a result of the experimental procedure, the prothrombin time was also measured after addition of 0.1 ml. of a 0.4 per cent solution of fibrinogen to 0.1 ml. of plasma.
Prolamine titration of heparin. The discovery (15) aqueous solution of protamine4 was used for the titration of heparin which was carried out as follows: to samples of 0.5 ml. of citrated plasma in 100 mm. by 13 mm. test tubes, decreasing quantities of protamine were added and then the plasma was recalcified by the addition of 0.1 ml. of 1.25 per cent CaCis and the clotting time noted at 370 C. Since protamine itself has a slight anticoagulant action, the amount of protamine required to neutralize heparin is that amount which gives the shortest clotting time of the plasma sample.
Fibrinogen estimation in the plasma. This was done by a modification of that method (16) which is based on the estimation of fibrin produced in plasma, diluted 30 times with saline, by the addition of calcium. In plasma containing heparin, this method gives uncertain results since fibrin formation on recalcification is considerably delayed by heparin. Thromboplastin, however, added in suitable quantities, overcomes the inhibitory action of such quantities of heparin as were used in this work. Accordingly, in samples of plasma containing heparin, the method was modified by the addition to the clotting mixture of 0.5 ml. of thromboplastin prepared according to Quick (17) . As shown elsewhere (18) , this modification permits an accurate estimation of fibrinogen in plasma containing quantities of heparin in excess of those used in this work.
A qualitative test for fibrinogen, sometimes used in this work, is based on the fact that if the quantity of fibrinogen in plasma is very small, no clot is produced on addition of CaC12 to the 30 times diluted plasma. In the absence of an anticoagulant, the failure of production of a clot, under these circumstances, is by itself sufficient indication that the level of fibrinogen is markedly decreased. In those experiments in which this test was used, the notation "decreased" without qualification is substituted for the quantitative determination in mgm. of fibrinogen.
RESULTS
The effect of intravenous injection of trypsin A. Lethal dose and autopsyfindings. As shown in Figure 1 
EN
In dogs (Table I) C. Effect on the blood coagulation mechanism. When heparin was given prior to the injection of trypsin, although the clotting time was found to be prolonged as the result of the injection of heparin, no significant changes were observed in the prothrombin time and the fibrinogen level (Table II, Effect of anaphylactic and peptone shock on blood coagulation mechanism For purposes of comparison, the blood coagulation mechanism following anaphylactic shock in 3 rabbits (Table V Post mortem examination failed to reveal gross intravascular coagulation in all animals dying from the injection. For instance, 2 of the 4 rabbits killed by the injection of 0.1 ml. of thrombin per kgm. of body weight had no gross intravascular coagulation. However, all rabbits injected with 0.2 ml. per kgm. of body weight showed gross intravascular coagulation at post mortem examination.
Of 4 dogs injected with 0.03 ml. of thrombin per kgm. of body weight, 1 died and showed no gross intravascular coagulation at post mortem examination.
B. Effect on blood pressure. A marked and immediate fall in blood pressure followed the injection of 0.1 ml. of thrombin or more per kgm. of body weight into rabbits (Table VIII, group  1) , and of 0.03 ml. in the only dog upon which the blood pressure was recorded (Table VIII, No. 6). A typical recording of the blood pressure during and after intravenous injection of thrombin, is given in Figure 3 .
C. Effect on the coagulation mechanism. A prolongation of the clotting time was observed after injection into rabbits of 0.1 ml. or more of thrombin per kgm. of body weight (Table VIII to normal by the addition of suitable quantities of protamine (Table VIII) and consequently was not due to the presence of heparin.
Effect of preliminary administration of heparin upon the syndrome of thrombin shock A. Effect of toxicity. A dose of 0.2 ml. of thrombin per kgm. of body weight, which proved lethal in all other injected rabbits, did not kill any of the 3 heparinized rabbits (Table VIII, group 2). B. Effect on the blood pressure. A typical tracing is given in Figure 3 (Rabbit No. 91). It was found that the intravenous injection of 0.2 ml. of thrombin in rabbits (Nos. 92 and 93) which had been previously heparinized had no effect on the blood pressure (Table VIII) .
C. Effect on blood coagulation mechanism. After such an injection of thrombin in 3 heparinized rabbits, the clotting time of whole blood and the clotting time of recalcified plasma were prolonged as a result of the injection of heparin, but the prothrombin time and the fibrinogen levels were not significantly altered (Table VIII, group 2).
DISCUSSION
The similarity of the states of shock produced by trypsin and by anaphylaxis has beeni emphasized (1 to 4). It was shown that in both conditions, histamine was released from smooth muscle and that histamine could account for some of the symptoms following the injection of trypsin. To heparin is attributed the prolongation of the clotting time observed during trypsin shock.
The data presented here permit a comparison between certain features of anaphvlactic shock and trypsin shock. A fall in blood pressure and a prolongation of the clotting time are observed in both conditions. In anaphylactic shock, the prolongation of the clotting time is clearly due to release of heparin (6) . As a result, the clotting time of recalcified plasma is markedly prolonged (Table V) . Moreover, suitable quan-tities of protamine, which neutralize heparin, bring back to normal the prolonged clotting time of recalcified plasma. Finally, the presence of an anticoagulant in plasma obtained during anaphylaxis is readily demonstrated by the prolongation of clotting time of normal plasma by such plasma. The prothrombin time has been shown not to be affected by quantities of heparin such as are found in anaphylactic (18) or peptone (17) shock and is, therefore, normal in these two conditions.
In trypsin shock, in the experiments reported here, the prolonged clotting time was associated with a prolonged prothrombin time, a slightly prolonged clotting time of recalcified plasma, and a decreased fibrinogen level in the plasma. The prolonged clotting time of recalcified plasma was, however, not shortened by the addition of suitable quantities of protamine, and the clotting time of normal plasma was not prolonged by the addition of trypsin shock plasma. It would, therefore, appear that the prolongation of the clotting time following intravenous injection of trypsin was not due to the presence of heparin or any other anticlotting agent and could be explained on the basis of the decreased prothrombin and fibrinogen.
The changes in blood coagulation observed after the intravenous injection of thrombin were identical with those following trypsin injections and were similarly associated with changes in the prothrombin and fibrinogen content of plasma. In the experiments reported here, no anticoagulant could be detected in the blood following intravenous injections of thrombin and, therefore, the prolongation of the clotting time appears to be due also to the change in prothrombin time and fibrinogen content of the plasma.
Preliminary administration of heparin prevented the decrease in fibrinogen content and lengthening of the prothrombin time caused by the injection of trypsin or of thrombin. This observation offers support to the thesis that the cause of the changes in the blood coagulation, as well as in fibrinogen and prothrombin concentrations, following the injection of both trypsin and of thrombin, lies in the coagulating activity of these substances. The simplest explanation for the decrease of fibrinogen and prothrombin following intravenous injection of trypsin or thrombin is that intravascular coagulation of the blood occurred. The absence of macroscopic clots in a number of instances is understandable if the fibrin so formed was deposited throughout the organism on the walls of the blood vessels. From 300 to 400 mgm. of fibrin from a blood volume of 200 ml. in a rabbit, deposited as a fine layer throughout the relatively enormous vascular bed, might well have escaped detection at autopsy. This theory is further supported by one experiment (dog No. la, Table I ) in which the usual prolonged clotting time was preceded by a shortened clotting time.
The decrease in prothrombin following the intravenous injection of thrombin would seem to indicate that in vivo, the injected thrombin produces fibrin from fibrinogen in the usual fashion but in addition, since calcium ions are present, and in contrast to what happens when it is added to citrated or oxalated blood, sets in motion the production of more thrombin from prothrombin with subsequent consumption of prothrombin and fibrinogen. When trypsin is injected, thrombin is, of course, formed from the action of trypsin on prothrombin and the action of the newly formed thrombin, identical with that of injected thrombin, may account for the small amount of trypsin required in vivo to produce coagulation, as compared to the relatively large amount (1 mgm. per 2 ml. of citrated blood) needed in vitro on citrated or oxalated blood containing no calcium ion. The possibility of such an explanation seems to have-been overlooked by other investigators of the action of thrombin (19) and trypsin (7) .
Trypsin differs from thrombin in that its vasodepressive action is not abolished by preliminary heparinization while that of thrombin is. This indicates that the vaso-depressive action of thrombin may be due entirely to its clotting activity. In the case of trypsin, however, the protective action of heparin against death, shown in Table IV , would seem to indicate that a part of the action of trypsin is due also to its clotting activity.
The paradoxical prolongation of the clotting time obtained in vivo by the injection of clotting agents must be considered in the search for injectable hemostatic agents to be used either in normal individuals or patients with bleeding tendencies, particularly hemophiliacs. It 
